Differences Between Women Who Pursued Genetic Testing for Hereditary Breast and Ovarian Cancer and Their At-Risk Relatives Who Did Not

Maria Katapodi

Laurel L. Northouse

Penny Pierce

Kara J. Milliron

Guipeng Liu

Sofia D. Merajver

hereditary, hereditary risk, breast neoplasms, ovarian neoplasms, women, cancer screening
ONF 2011, 38(5), 572-581. DOI: 10.1188/11.ONF.572-581

Purpose/Objectives: To (a) examine differences in appraisals of hereditary breast and ovarian cancer (HBOC), psychological distress, family environment, and decisional conflict between women who pursued genetic testing and their at-risk relatives who did not, and (b) examine correlations among appraisals of HBOC, psychological distress, family environment, and decisional conflict regarding genetic testing in these two cohorts of women.

Design: Descriptive, cross-sectional cohort study.

Setting: Two clinics affiliated with a major research university in the midwestern United States.

Sample: 372 women aged 18 years and older. 200 pursued genetic testing for BRCA1 and BRCA2 mutations (probands) and 172 of their female relatives who had a greater than 10% prior probability of being a mutation carrier but had not pursued testing.

Methods: After providing informed consent, probands and relatives were mailed self-administered questionnaires.

Main Research Variables: Perceived risk, knowledge of HBOC risk factors and modes of gene inheritance, perceived severity, perceived controllability, psychological distress, family relationships, family communication, and decisional conflict about genetic testing.

Findings: T tests revealed that probands perceived higher risk and had more psychological distress associated with breast cancer. Probands had more knowledge regarding risk factors and gene inheritance, and greater decisional conflict regarding genetic testing. Relatives reported higher perceived severity and controllability. No differences were observed in family relationships and family communication between probands and relatives. Pearson correlations revealed different patterns in knowledge, perceived controllability, family relationships, and decisional conflict between probands and relatives.

Conclusions: Significant differences exist between women who pursue genetic testing and those who do not. The family environment influences adjustment to HBOC and decisions about genetic testing.

Implications for Nursing: Enhancing the family communication process about HBOC can provide informational and emotional support to high-risk women and promote decision making about genetic testing.

Jump to a section


    American Cancer Society. (2011). Cancer facts and figures 2011. Retrieved from
    Anagnostopoulos, F., & Spanea, E. (2005). Assessing illness representations of breast cancer: A comparison of patients with healthy and benign controls. Journal of Psychosomatic Research, 58, 327-334.
    Berry, D. A., Iversen, E. S., Jr., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., … Parmigiani, G. (2002). BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. Journal of Clinical Oncology, 20, 2701-2712.
    Biesecker, B. B., Ishibe, N., Hadley, D. W., Giambarresi, T. R., Kase, R. G., Lerman, C., & Struewing, J. P. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. American Journal of Medical Genetics, 93, 257-263.
    Blandy, C., Chabal, F., Stoppa-Lyonnet, D., & Julian-Reynier, C. (2003). Testing participation in BRCA1/2-positive families: Initiator role of index cases. Genetic Testing, 7, 225-233.
    Cameron, L. D., & Muller, C. (2009). Psychosocial aspects of genetic testing. Current Opinion in Psychiatry, 22, 218-223.
    Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. American Journal of Medical Genetics, 116A, 11-19.
    Claes, E., Evers-Kiebooms, G., Denayer, L., Decruyenaere, M., Boogaerts, A., Philippe, K., & Leguis, E. (2005). Predictive genetic testing for hereditary breast and ovarian cancer: Psychological distress and illness representations 1 year following disclosure. Journal of Genetic Counseling, 14, 349-363.
    Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopfer, J., Campeau, L., … Weber, B. L. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New England Journal of Medicine, 336, 1409-1415.
    Crotser, C. B., & Boehmke, M. (2009). Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: State of the science. Journal of Cancer Survivorship, 3, 21-42.
    d'Agincourt-Canning, L. (2005). The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. Journal of Genetic Counseling, 14(1), 55-69.
    Eisinger, F., Charafe-Jauffret, E., Jacquemier, J., Birnbaum, D., Julian-Reynier, C., & Sobol, H. (2001). Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: Computed efficacy, effectiveness and impact. International Journal of Oncology, 18(1), 5-10.
    Finch, A., Beiner, M., Lubinski, J., Lynch, H. T., Moller, P., Rosen, B., … Narod, S. A. (2006). Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA, 296, 185-192.
    Frank, T. S. (1999). Testing for hereditary risk for ovarian cancer. Cancer Control, 6, 327-334.
    Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., … Miki, Y. (1994). BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122.
    Geller, G., Doksum, T., Bernhardt, B. A., & Metz, S. A. (1999). Participation in breast cancer susceptibility testing protocols: Influence of recruitment source, altruism, and family involvement on women's decisions. Cancer Epidemiology, Biomarkers and Prevention, 8, 377-383.
    Gooding, H. C., Organista, K., Burack, J., & Biesecker, B. B. (2006). Genetic susceptibility testing from a stress and coping perspective. Social Science and Medicine, 62, 1880-1890.
    Gurmankin, A. D., Domchek, S., Stopfer, J., Fels, C., & Armstrong, K. (2005). Patients' resistance to risk information in genetic counseling for BRCA1/2. Archives of Internal Medicine 165, 523-529.
    Halbert, C. H., Kessler, L., Stopfer, J. E., Domchek, S., & Wileyto, E. P. (2006). Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genetics in Medicine, 8, 576-582.
    Hamilton, R. J., Bowers, B. J., & Williams, J. K. (2005). Disclosing genetic test results to family members. Journal of Nursing Scholarship, 37(1), 18-24.
    Hughes, C., Lerman, C., Schwartz, M., Peshkin, B. N., Wenzel, L., Narod, S., … Main, D. (2002). All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. American Journal of Medical Genetics, 107, 143-150.
    Janis, I. L., & Mann, L. (1977). Decision-making: A psychological analysis of conflict, choice, and commitment. New York, NY: Free Press.
    Katapodi, M. C., & Aouizerat, B. E. (2005). Do women in the community recognize hereditary and sporadic breast cancer risk factors? Oncology Nursing Forum, 32, 617-623.
    Katapodi, M. C., Dodd, M. J., Facione, N. C., Humphreys, J. C., & Lee, K. A. (2010). Why some women have an optimistic or a pessimistic bias about breast cancer risk: Experiences, heuristics, and knowledge of risk factors. Cancer Nursing, 33, 64-73.
    Katapodi, M. C., Dodd, M. J., Lee, K. A., & Facione, N. C. (2009). Underestimation of breast cancer risk: Influence on screening behavior. Oncology Nursing Forum, 36, 306-314.
    Keenan, L. A., Lesniak, K. T., Guarnaccia, C. A., Althaus, B., Ethington, G., & Blum, J. L. (2004). Family environments of women seeking BRCA1/BRCA2 genetic mutation testing: An exploratory analysis. Journal of Genetic Counseling, 13, 157-176.
    Kelly, K., Leventhal, H., Andrykowski, M., Toppmeyer, D., Much, J., Dermody, J., … Schwalb, M. (2004). The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations. Journal of Genetic Counseling, 13, 237-257.
    Kelly, K., Leventhal, H., Andrykowski, M., Toppmeyer, D., Much, J., Dermody, J., … Schwalb, M. (2005). Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psycho-Oncology, 14, 34-48.
    Landsbergen, K., Verhaak, C., Kraaimaat, F., & Hoogerbrugge, N. (2005). Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Familial Cancer, 4, 115-119.
    Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York, NY: Springer.
    Lerman, C., Croyle, R. T., Tercyak, K. P., & Hamann, H. (2002). Genetic testing: Psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70, 784-797.
    McCubbin, H. I., Thompson, A. I., & McCubbin, M. A. (1996). FPSC: Family problem solving communication. In H. I. McCubbin, A. I. Thompson & M. A. McCubbin (Eds.), Family assessment: Resiliency, coping, and adaptation(pp. 639-684). Madison, WI: University of Wisconsin.
    Mellon, S., Berry-Bobovski, L., Gold, R., Levin, N., & Tainsky, M. A. (2006). Communication and decision-making about seeking inherited cancer risk information: Findings from female survivor-relative focus groups. Psycho-Oncology, 15, 193-208.
    Mellon, S., Gold, R., Janisse, J., Cichon, M., Tainsky, M. A., Simon, M. S., & Korczak, J. (2008). Risk perception and cancer worries in families at increased risk of familial breast/ovarian cancer. Psycho-Oncology, 17, 756-766.
    Metcalfe, K. A., Birenbaum-Carmeli, D., Lubinski, J., Gronwald, J., Lynch, H., Moller, P., … Narod, S. A. (2008). International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer, 122, 2017-2022.
    Moos, R. H. (1987). The Social Climate Scales: A user's guide. Palo Alto, CA: Consulting Psychologists.
    Moos, R. H. (1990). Conceptual and empirical approaches to developing family-based assessment procedures: Resolving the case of the Family Environment Scale. Family Process, 29, 199-208.
    Moss-Morris, R., Weinman, J., Petrie, K. J., Horne, R., Cameron, L. D., & Buick, D. (2002). The revised Illness Perception Questionnaire (IPQ-R). Psychology and Health, 17(1), 1-16.
    Nycum, G., Avard, D., & Knoppers, B. M. (2009). Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information. European Journal of Human Genetics, 17, 872-880.
    O'Connor, A. M. (1995). Validation of a decisional conflict scale. Medical Decision Making, 15(1), 25-30.
    Pasacreta, J. V. (2003). Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: An integrative review. Cancer Investigation, 21, 588-623.
    Peterson, S. K. (2005). The role of the family in genetic testing: Theoretical perspectives, current knowledge, and future directions. Health Education and Behavior, 32, 627-639.
    Peterson, S. K., Pentz, R. D., Marani, S. K., Ward, P. A., Blanco, A. M., LaRue, D., … Strong, L. C. (2008). Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome. Psycho-Oncology, 17, 783-789.
    Rees, G., Fry, A., Cull, A., & Sutton, S. (2004). Illness perceptions and distress in women at increased risk of breast cancer. Psychology and Health, 19, 749-765.
    Reichelt, J. G., Møller, P., Heimdal, K., & Dahl, A. A. (2008). Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer. Familial Cancer, 7, 245-254.
    Rini, C., O'Neill, S. C., Valdimarsdottir, H., Goldsmith, R. E., Jandorf, L., Brown, K., … Schwartz, M. D. (2009). Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results. Health Psychology, 28, 569-578.
    Rolland, J. S., & Williams, J. K. (2005). Toward a biopsychosocial model for 21st-century genetics. Family Process, 44(1), 3-24.
    Ropka, M. E., Wenzel, J., Phillips, E. K., Siadaty, M., & Philbrick, J. T. (2006). Uptake rates for breast cancer genetic testing: A systematic review. Cancer Epidemiology, Biomarkers and Prevention, 15, 840-855.
    Schrag, D., Kuntz, K. M., Garber, J. E., & Weeks, J. C. (1997). Decision analysis-Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. New England Journal of Medicine, 336, 1465-1471.
    Schwartz, M. D., Peshkin, B. N., Tercyak, K. P., Taylor, K. L., & Valdi-marsdottir, H. (2005). Decision making and decision support for hereditary breast/ovarian cancer susceptibility. Health Psychology, 24(4, Suppl.), S78-S84.
    Speice, J., McDaniel, S. H., Rowley, P. T., & Loader, S. (2002). Family issues in a psychoeducation group for women with a BRCA mutation. Clinical Genetics, 62, 121-127.
    Tercyak, K. P., Demarco, T., Mars, B. D., & Peshkin, B. N. (2004). Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: Psychological aspects. American Journal of Medical Genetics, 131(A), 36-41.
    Tercyak, K. P., Peshkin, B. N., DeMarco, T. A., Patenaude, A. F., Schneider, K. A., Garber, J. E., … Schwartz, M. D. (2007). Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genetic Testing, 11, 249-255.
    Trask, P. C., Paterson, A. G., Wang, C., Hayasaka, S., Milliron, K. J., Blumberg, L. R., … Merajver, S. D. (2001). Cancer-specific worry interference in women a breast and ovarian cancer risk evaluation program: Impact on emotional distress and health functioning. Psycho-Oncology, 10, 349-360.
    van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Bröcker-Vriends, A. H., van Asperen, C. J., Sijmons, R. H., … Tibben, A. (2007a). The common sense model of self-regulation and psychological adjustment to predictive genetic testing: A prospective study. Psycho-Oncology, 16, 1121-1129.
    van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Bröcker-Vriends, A. H., van Asperen, C. J., Sijmons, R. H., … Tibben, A. (2007b). Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPC genetic susceptibility testing. European Journal of Cancer, 43, 71-77.
    Wang, C., Gonzalez, R., Milliron, K. J., Strecher, V. J., & Merajver, S. D. (2005). Genetic counseling for BRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics, 134A, 66-73.
    Wilson, B. J., Forrest, K., van Teijlingen, E. R., McKee, L., Haites, N., Matthews, E., & Simpson, S. A. (2004). Family communication about genetic risk: The little that is known. Community Genetics, 7(1), 15-24.
    Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., … Micklem, G. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-792.
    Wylie, J. E., Smith, K. R., & Botkin, J. R. (2003). Effects of spouses on distress experienced by BRCA1 mutation carriers over time. American Journal of Medical Genetics, 119C, 35-44.